about
Dietary sources of inorganic microparticles and their intake in healthy subjects and patients with Crohn's diseaseProbiotics for preventing preterm labourProbiotics for preventing preterm labourModulating Composition and Metabolic Activity of the Gut Microbiota in IBD PatientsA prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptomsConservative treatment for anal incontinence.Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.Intestinal microflora as a therapeutic target in inflammatory bowel disease.Randomised clinical trial of synbiotic therapy in elective surgical patientsPosttraumatic inflammation is a complex response based on the pathological expression of the nervous, immune, and endocrine functional systems.The Efficacy of Probiotic (Lactobacillus rhamnosus GG) and 5-ASA (Aminosalicylic Acid) in the Treatment of Experimental Radiation Proctitis in RatsGut microflora: a new target for therapeutic approaches in inflammatory bowel disease.Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human healthThe dual role of bacteriocins as anti- and probiotics.Critical illness, gastrointestinal complications, and medication therapy during enteral feeding in critically ill adult patients.Enteral nutrition in patients with severe traumatic brain injury: reasons for intolerance and medical management.Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin.Mucosal intestinal alteration in experimental colitis correlates with nitric oxide production by peritoneal macrophages: effect of probiotics and prebiotics.Probiotics and Synbiotics Decrease Postoperative Sepsis in Elective Gastrointestinal Surgical Patients: a Meta-Analysis.Towards the control of necrotic enteritis in broiler chickens with in-feed antibiotics phasing-out worldwide.
P2860
Q22248061-CBA03972-0F51-4F3B-A781-08128CFFAEE3Q24244075-13459760-0EF7-434A-85E1-331AB255A71CQ24246388-7BF6A96F-6CC8-41D6-AA04-17859BBE282DQ26750985-E8D220C5-503F-4B9F-90AD-2B4E7CD56CA7Q30891703-00AD9E6E-CCBA-4EDC-816F-9CC3E4C2D1B8Q33607191-68EF1636-9128-4C74-83B5-2618792F22ABQ34588415-B96C7239-29DE-488A-8F47-175A380FAA97Q35062098-4964DE9A-E917-4B51-8E8E-F903F2662995Q35598284-19BA3BAB-17A6-45C5-B2C7-6239A0DD762DQ35634267-11EFE0A0-DAE9-4956-AE9E-BAD3DD900441Q36408869-7E0996B1-AA74-41F8-BC8A-6A687F69C769Q37082773-0EB310BC-8F17-4BB5-9DF9-99894994B2ECQ37122143-213EC817-3B97-436B-9C45-F45C8209B73DQ37160785-AAF93EBB-D36C-4E6A-B0BC-8BCAE8ED3607Q37686927-05A3E54B-CC1A-4D9E-9C14-E120604BEFE8Q37842446-1C9CD5CF-6658-472D-B2E0-EF541615A56EQ41761349-1E3D00C5-4542-4427-B2AC-6DA9380A510FQ46881285-6C095CDC-2503-40EB-A750-63ED436B87E5Q50202853-8D3E2A6F-02F0-45E5-BC5F-65F469E46C73Q55111392-E85021AC-BD9C-4A17-86B0-8FDF1515EF70
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pre-, pro- and synbiotics.
@ast
Pre-, pro- and synbiotics.
@en
Pre-, pro- and synbiotics.
@nl
type
label
Pre-, pro- and synbiotics.
@ast
Pre-, pro- and synbiotics.
@en
Pre-, pro- and synbiotics.
@nl
prefLabel
Pre-, pro- and synbiotics.
@ast
Pre-, pro- and synbiotics.
@en
Pre-, pro- and synbiotics.
@nl
P1476
Pre-, pro- and synbiotics
@en
P304
P356
10.1097/00075197-200111000-00019
P577
2001-11-01T00:00:00Z